title: Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.
abstract: BACKGROUND
  To correlate the metabolic changes with size changes for tumor response by concomitant PET-CT evaluation of lung cancers after radiotherapy.
  
  
  METHODS
  36 patients were studied pre- and post-radiotherapy with18FDG PET-CT scans at a median interval of 71 days. All of the patients were followed clinically and radiographically after a mean period of 342 days for assessment of local control or failure rates. Change in size (sum of maximum orthogonal diameters) was correlated with that of maximum standard uptake value (SUV) of the primary lung cancer before and after conventional radiotherapy.
  
  
  RESULTS
  There was a significant reduction in both SUV and size of the primary cancer after radiotherapy (p < 0.00005). Among the 20 surviving patients, the sensitivity, specificity, and accuracy using PET (SUV) were 94%, 50%, 90% respectively and the corresponding values using and CT (size criteria) were 67%, 50%, and 65% respectively. The metabolic change (SUV) was highly correlated with the change in size by a quadratic function. In addition, the mean percentage metabolic change was significantly larger than that of size change (62.3 +/- 32.7% vs 47.1 +/- 26.1% respectively, p = 0.03)
  
  
  CONCLUSIONS
  Correlating and incorporating metabolic change by PET into size change by concomitant CT is more sensitive in assessing therapeutic response than CT alone.
authors.affiliation: Nuclear Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA. owong@beaumont.edu
authors.forename: Ching-Yee O
authors.initials: CY
authors.lastname: Wong
authors.forename: Joseph
authors.initials: J
authors.lastname: Schmidt
authors.forename: Jeffery S
authors.initials: JS
authors.lastname: Bong
authors.forename: Suyra
authors.initials: S
authors.lastname: Chundru
authors.forename: Larry
authors.initials: L
authors.lastname: Kestin
authors.forename: Di
authors.initials: D
authors.lastname: Yan
authors.forename: Inga
authors.initials: I
authors.lastname: Grills
authors.forename: Marianne
authors.initials: M
authors.lastname: Gaskill
authors.forename: Vincent
authors.initials: V
authors.lastname: Cheng
authors.forename: Alvaro A
authors.initials: AA
authors.lastname: Martinez
authors.forename: Darlene
authors.initials: D
authors.lastname: Fink-Bennett
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000532:radiotherapy*; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D049268:Positron-Emission Tomography / Q000379:methods*; D011878:Radiotherapy / Q000379:methods*; D015203:Reproducibility of Results; D055752:Small Cell Lung Carcinoma / Q000473:pathology / Q000532:radiotherapy*; D013997:Time Factors; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D019788:Fluorodeoxyglucose F18